Related Experiment Video
Updated: Aug 28, 2025

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
Published on: October 25, 2024
γ-Tocotrienol inhibits T helper 17 cell differentiation via the IL-6/JAK/STAT3 signaling pathway
Hanqing Zhao1, Xin Guo1, Yunxuan Lei1
1Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology, Shanghai 200025, China.
Abstract:
γ-Tocotrienol (GT3), a member of the vitamin E family, is well known for its medicinal value in clinical treatments. However, the role of GT3 in T helper 17 (Th17)/regulatory T cell (Treg) differentiation and function is not fully understood. Here, we demonstrated that GT3 suppressed Th17 differentiation in vitro by inhibiting signal transducer and activator of transcription 3 (STAT3) phosphorylation in the interleukin 6 (IL-6)/Janus kinase (JAK)/STAT3 signaling pathway. GT3 also inhibited HIF1A expression in Th17 metabolism. Additionally, we showed that GT3 treatment inhibited disease aggravation in an imiquimod (IMQ)-induced psoriasis-like mouse model by reducing the percentage of Th17 cells in the spleen in vivo. The findings of this study demonstrated the effects of GT3 on Th17 cells through the STAT3 signaling pathway.
Insights
Gamma-tocotrienol (GT3) suppresses T helper 17 cell differentiation by inhibiting the IL-6/JAK/STAT3 pathway. This vitamin E compound also reduced disease severity in a mouse model of psoriasis.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- γ-Tocotrienol (GT3), a vitamin E derivative, possesses known medicinal properties.
- The precise role of GT3 in T helper 17 (Th17) and regulatory T cell (Treg) differentiation and function remains unclear.
- Th17 cells are implicated in various autoimmune diseases, making their regulation a key therapeutic target.
Purpose of the Study:
- To investigate the effect of γ-tocotrienol (GT3) on T helper 17 (Th17) cell differentiation and function.
- To elucidate the molecular mechanisms underlying GT3's influence on Th17 cells.
- To evaluate the therapeutic potential of GT3 in an in vivo model of inflammation.
Main Methods:
- In vitro assessment of Th17 differentiation with GT3 treatment.
- Analysis of signal transducer and activator of transcription 3 (STAT3) phosphorylation in the interleukin 6 (IL-6)/Janus kinase (JAK)/STAT3 pathway.
- Evaluation of hypoxia-inducible factor 1-alpha (HIF1A) expression in Th17 cells.
- In vivo study using an imiquimod (IMQ)-induced psoriasis-like mouse model.
Main Results:
- GT3 suppressed Th17 cell differentiation in vitro.
- GT3 inhibited STAT3 phosphorylation within the IL-6/JAK/STAT3 signaling pathway.
- GT3 reduced HIF1A expression, impacting Th17 cell metabolism.
- In vivo, GT3 treatment ameliorated disease severity in the IMQ-induced psoriasis model by decreasing splenic Th17 cell populations.
Conclusions:
- γ-Tocotrienol (GT3) effectively suppresses Th17 cell differentiation and function.
- The mechanism involves the inhibition of the IL-6/JAK/STAT3 signaling pathway and modulation of Th17 cell metabolism.
- GT3 demonstrates therapeutic potential for inflammatory conditions like psoriasis by targeting Th17 cells.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

